 |
Interferon beta (recombinant) |
|---|---|
| Trade Name | R-Ifn-Beta |
| Orphan Indication | For the systemic treatment of metastatic renal cell carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1991-02-12 00:00:00 |
| Sponsor | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 |
